Mollification of Doxorubicin (DOX)-Mediated Cardiotoxicity Using Conjugated Chitosan Nanoparticles with Supplementation of Propionic Acid

Overview

Journal Nanomaterials (Basel)

Date 2022 Feb 15

PMID 35159847

Authors

Durairaj Siva

Subramanian Abinaya

Durairaj Rajesh

Govindaraju Archunan

Parasuraman Padmanabhan

Balazs Gulyas

Shanmugam Achiraman

Affiliations

Soon will be listed here.

Abstract

Doxorubicin is an extensively prescribed antineoplastic agent. It is also known for adverse effects, among which cardiotoxicity tops the list. The possible mechanism underlying doxorubicin (DOX)-mediated cardiotoxicity has been investigated in this study. Further, to reduce the DOX-mediated cardiotoxicity, DOX was conjugated with Chitosan Nanoparticles (DCNPs) and supplemented with propionic acid. Initially, the drug loading efficacy and conjugation of DOX with chitosan was confirmed by UV-Visible Spectroscopy (UV) and Fourier Transform Infrared Spectroscopy (FTIR). The average sizes of the synthesized Chitosan Nanoparticles (CNPs) and DCNPs were measured by Dynamic Light Scattering (DLS) analysis as 187.9 ± 1.05 nm and 277.3 ± 8.15 nm, respectively, and the zeta potential values were recorded as 55.2 ± 0.7 mV and 51.9 ± 1.0 mV, respectively. The size and shape of CNPs and DCNPs were recorded using a High-Resolution Electron Microscopy (HRTEM). The particles measured <30 nm and 33-84 nm, respectively. The toxic effects of DCNPs and propionic acid were evaluated in rat model. The data from the electrocardiogram (ECG), cardiac biomarkers, Peroxisome proliferator-activated receptor gamma (PPARγ) and histological observations indicated evidence of DOX-mediated cardiotoxicity, whereas the administration of DCNPs, as well as Propionic Acid (PA), brought about a restoration to normalcy and offered protection in the context of DOX-induced cardiotoxicity.

Citing Articles

Jingzhi Guanxin Oral Liquids Attenuate Atherosclerotic Coronary Heart Disease via Modulating Lipid Metabolism and PPAR-Related Targets.

Wang X, Hu T, Jiang Y, He Y, Li P, Peng W Pharmaceuticals (Basel). 2024; 17(6).

PMID: 38931451 PMC: 11206304. DOI: 10.3390/ph17060784.

ULK1 Mediated Autophagy-Promoting Effects of Rutin-Loaded Chitosan Nanoparticles Contribute to the Activation of NF-κB Signaling Besides Inhibiting EMT in Hep3B Hepatoma Cells.

Wu P, Wang X, Yin M, Zhu W, Chen Z, Zhang Y Int J Nanomedicine. 2024; 19:4465-4493.

PMID: 38779103 PMC: 11110815. DOI: 10.2147/IJN.S443117.

Box-Behnken Design: Optimization of Proanthocyanidin-Loaded Transferosomes as an Effective Therapeutic Approach for Osteoarthritis.

Tamilarasan N, Yasmin B, Anitha P, Umme H, Cheng W, Mohan S Nanomaterials (Basel). 2022; 12(17).

PMID: 36079990 PMC: 9457895. DOI: 10.3390/nano12172954.

References

Antony J, Ayisha Sithika M, Joseph T, Suriyakalaa U, Sankarganesh A, Siva D . In vivo antitumor activity of biosynthesized silver nanoparticles using Ficus religiosa as a nanofactory in DAL induced mice model. Colloids Surf B Biointerfaces. 2013; 108:185-90. DOI: 10.1016/j.colsurfb.2013.02.041. View

Mattaveewong T, Wongkrasant P, Chanchai S, Pichyangkura R, Chatsudthipong V, Muanprasat C . Chitosan oligosaccharide suppresses tumor progression in a mouse model of colitis-associated colorectal cancer through AMPK activation and suppression of NF-κB and mTOR signaling. Carbohydr Polym. 2016; 145:30-6. DOI: 10.1016/j.carbpol.2016.02.077. View

Al-Lahham S, Peppelenbosch M, Roelofsen H, Vonk R, Venema K . Biological effects of propionic acid in humans; metabolism, potential applications and underlying mechanisms. Biochim Biophys Acta. 2010; 1801(11):1175-83. DOI: 10.1016/j.bbalip.2010.07.007. View

Antony J, Sivalingam P, Siva D, Kamalakkannan S, Anbarasu K, Sukirtha R . Comparative evaluation of antibacterial activity of silver nanoparticles synthesized using Rhizophora apiculata and glucose. Colloids Surf B Biointerfaces. 2011; 88(1):134-40. DOI: 10.1016/j.colsurfb.2011.06.022. View

Wu J, Hu X, Liu R, Zhang J, Song A, Luan Y . pH-responsive and self-targeting assembly from hyaluronic acid-based conjugate toward all-in-one chemo-photodynamic therapy. J Colloid Interface Sci. 2019; 547:30-39. DOI: 10.1016/j.jcis.2019.03.087. View

Kashyap P, Xiang X, Heiden P . Chitosan nanoparticle based delivery systems for sustainable agriculture. Int J Biol Macromol. 2015; 77:36-51. DOI: 10.1016/j.ijbiomac.2015.02.039. View

Mohammed Asik R, Manikkaraja C, Tamil Surya K, Suganthy N, Priya Aarthy A, Mathe D . Anticancer Potential of L-Histidine-Capped Silver Nanoparticles against Human Cervical Cancer Cells (SiHA). Nanomaterials (Basel). 2021; 11(11). PMC: 8618575. DOI: 10.3390/nano11113154. View

Nattel S, Shiroshita-Takeshita A, Brundel B, Rivard L . Mechanisms of atrial fibrillation: lessons from animal models. Prog Cardiovasc Dis. 2005; 48(1):9-28. DOI: 10.1016/j.pcad.2005.06.002. View

Zhang P, Zhang H, He W, Zhao D, Song A, Luan Y . Disulfide-Linked Amphiphilic Polymer-Docetaxel Conjugates Assembled Redox-Sensitive Micelles for Efficient Antitumor Drug Delivery. Biomacromolecules. 2016; 17(5):1621-32. DOI: 10.1021/acs.biomac.5b01758. View

10.

Iliskovic N, Singal P . Lipid lowering: an important factor in preventing adriamycin-induced heart failure. Am J Pathol. 1997; 150(2):727-34. PMC: 1858278. View

11.

Sugano M, Watanabe S, Kishi A, Izume M, Ohtakara A . Hypocholesterolemic action of chitosans with different viscosity in rats. Lipids. 1988; 23(3):187-91. DOI: 10.1007/BF02535456. View

12.

Zhang M, Zhu J, Zheng Y, Guo R, Wang S, Mignani S . Doxorubicin-Conjugated PAMAM Dendrimers for pH-Responsive Drug Release and Folic Acid-Targeted Cancer Therapy. Pharmaceutics. 2018; 10(3). PMC: 6160908. DOI: 10.3390/pharmaceutics10030162. View

13.

Arulmozhi V, Pandian K, Mirunalini S . Ellagic acid encapsulated chitosan nanoparticles for drug delivery system in human oral cancer cell line (KB). Colloids Surf B Biointerfaces. 2013; 110:313-20. DOI: 10.1016/j.colsurfb.2013.03.039. View

14.

Marklund S, Marklund G . Involvement of the superoxide anion radical in the autoxidation of pyrogallol and a convenient assay for superoxide dismutase. Eur J Biochem. 1974; 47(3):469-74. DOI: 10.1111/j.1432-1033.1974.tb03714.x. View

15.

Singal P, Li T, Kumar D, Danelisen I, Iliskovic N . Adriamycin-induced heart failure: mechanism and modulation. Mol Cell Biochem. 2000; 207(1-2):77-86. DOI: 10.1023/a:1007094214460. View

16.

Burnett C, Li C, Webber E, Tsaousidou E, Xue S, Bruning J . Hunger-Driven Motivational State Competition. Neuron. 2016; 92(1):187-201. PMC: 5082717. DOI: 10.1016/j.neuron.2016.08.032. View

17.

Renu K, V G A, P B T, Arunachalam S . Molecular mechanism of doxorubicin-induced cardiomyopathy - An update. Eur J Pharmacol. 2017; 818:241-253. DOI: 10.1016/j.ejphar.2017.10.043. View

18.

Hara H, Haga S, Aoyama Y, Kiriyama S . Short-chain fatty acids suppress cholesterol synthesis in rat liver and intestine. J Nutr. 1999; 129(5):942-8. DOI: 10.1093/jn/129.5.942. View

19.

Ridker P . Clinical application of C-reactive protein for cardiovascular disease detection and prevention. Circulation. 2003; 107(3):363-9. DOI: 10.1161/01.cir.0000053730.47739.3c. View

20.

Zhang H, Tao Y, Guo J, Hu Y, Su Z . Hypolipidemic effects of chitosan nanoparticles in hyperlipidemia rats induced by high fat diet. Int Immunopharmacol. 2011; 11(4):457-61. DOI: 10.1016/j.intimp.2010.12.015. View